{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:03:36Z","timestamp":1782806616311,"version":"3.54.5"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2017YFE0102200"],"award-info":[{"award-number":["2017YFE0102200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Program of China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ajps.2018.12.004","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T01:56:38Z","timestamp":1549245398000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Recent strategies on targeted delivery of thrombolytics"],"prefix":"10.1016","volume":"14","author":[{"given":"Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1747-665X","authenticated-orcid":false,"given":"Ni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7181","key":"10.1016\/j.ajps.2018.12.004_bib0001","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"issue":"10100","key":"10.1016\/j.ajps.2018.12.004_bib0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"9658","key":"10.1016\/j.ajps.2018.12.004_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"issue":"9990","key":"10.1016\/j.ajps.2018.12.004_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"10096","key":"10.1016\/j.ajps.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(17)31441-1","article-title":"Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis","volume":"390","author":"Jinatongthai","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0006","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acs.molpharmaceut.7b00793","article-title":"Mitochondrial targeted doxorubicin-triphenylphosphonium delivered by hyaluronic acid modified and pH responsive nanocarriers to breast tumor: in vitro and in vivo Studies","volume":"15","author":"Liu","year":"2018","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.ajps.2018.12.004_bib0007","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/aps.2018.9","article-title":"Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ajps.2018.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2147\/IJN.S96862","article-title":"Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo","volume":"11","author":"Liu","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"22","key":"10.1016\/j.ajps.2018.12.004_bib0009","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","article-title":"Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2015.05.007","article-title":"Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice","volume":"209","author":"Zhang","year":"2015","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nano.2013.06.003","article-title":"Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection","volume":"10","author":"Zhang","year":"2014","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2010.05.015","article-title":"Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy","volume":"147","author":"Hu","year":"2010","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.ajps.2018.12.004_bib0013","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1021\/mp300254s","article-title":"Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection","volume":"9","author":"Hu","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2018.12.004_bib0014","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-0363-4_5","article-title":"Recombinant stem cells as carriers for cancer gene therapy","volume":"1141","author":"Hu","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","article-title":"Antiplatelet therapies for the treatment of cardiovascular disease","volume":"9","author":"Michelson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"10.1016\/j.ajps.2018.12.004_bib0016","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"issue":"Pt A","key":"10.1016\/j.ajps.2018.12.004_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.04.021","article-title":"Drug delivery with living cells","volume":"106","author":"Fliervoet","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2018.12.004_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.02.041","article-title":"Cell membrane-derived nanomaterials for biomedical applications","volume":"128","author":"Fang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2018.12.004_bib0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.01.048","article-title":"Cell-mediated delivery of synthetic nano- and microparticles","volume":"259","author":"Ayer","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2018.12.004_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ajps.2018.12.004_bib0021","doi-asserted-by":"crossref","first-page":"e14365","DOI":"10.1136\/bmjopen-2016-014365","article-title":"Microbubbles and UltraSound-accelerated Thrombolysis (MUST) for peripheral arterial occlusions: protocol for a phase II single-arm trial","volume":"7","author":"Ebben","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0022","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ane.12861","article-title":"Contrast-enhanced sonothrombolysis in acute ischemic stroke patients without intracranial large-vessel occlusion","volume":"137","author":"Kvistad","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ajps.2018.12.004_bib0023","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12883-015-0359-4","article-title":"A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)","volume":"15","author":"Nacu","year":"2015","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1552-6569.2008.00357.x","article-title":"Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis","volume":"20","author":"Ribo","year":"2010","journal-title":"J Neuroimaging"},{"issue":"21","key":"10.1016\/j.ajps.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.jacc.2016.03.542","article-title":"Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles","volume":"67","author":"Mathias","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0026","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ultrasmedbio.2011.11.001","article-title":"Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the Sonolysis study","volume":"38","author":"Slikkerveer","year":"2012","journal-title":"Ultrasound Med Biol"},{"issue":"19","key":"10.1016\/j.ajps.2018.12.004_bib0027","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.biomaterials.2009.02.034","article-title":"Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles","volume":"30","author":"Ma","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2018.12.004_bib0028","first-page":"5159","article-title":"Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis","volume":"7","author":"Yang","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2018.12.004_bib0029","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.2147\/IJN.S36197","article-title":"Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle","volume":"7","author":"Chen","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.RES.0000232317.84122.0c","article-title":"Conformation-specific blockade of the integrin GPIIb\/IIIa: a novel antiplatelet strategy that selectively targets activated platelets","volume":"99","author":"Schwarz","year":"2006","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.753657","article-title":"Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis","volume":"118","author":"von Zur","year":"2008","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ajps.2018.12.004_bib0032","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1161\/CIRCULATIONAHA.111.030312","article-title":"Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice","volume":"125","author":"Wang","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0033","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11239-010-0450-z","article-title":"Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research","volume":"30","author":"Hua","year":"2010","journal-title":"J Thromb Thrombolysis"},{"issue":"1\u20132","key":"10.1016\/j.ajps.2018.12.004_bib0034","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2010.10.028","article-title":"Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents","volume":"403","author":"Vaidya","year":"2011","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.ajps.2018.12.004_bib0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ultras.2009.05.003","article-title":"Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS","volume":"49","author":"Mu","year":"2009","journal-title":"Ultrasonices"},{"issue":"6","key":"10.1016\/j.ajps.2018.12.004_bib0036","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1021\/acsnano.7b02308","article-title":"Fibrin-targeted and H2O2-responsive nanoparticles as a theranostics for thrombosed vessels","volume":"11","author":"Kang","year":"2017","journal-title":"Acs Nano"},{"issue":"7","key":"10.1016\/j.ajps.2018.12.004_bib0037","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/nnm.11.179","article-title":"Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy","volume":"7","author":"McCarthy","year":"2012","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0301-5629(01)00522-1","article-title":"Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100\u202fkHz","volume":"28","author":"Suchkova","year":"2002","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.ajps.2018.12.004_bib0039","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0049-3848(00)00319-4","article-title":"Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise","volume":"100","author":"Sakharov","year":"2000","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ajps.2018.12.004_bib0040","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1121\/1.396636","article-title":"Particle gathering and microstreaming near ultrasonically activated gas-filled micropores","volume":"84","author":"Miller","year":"1988","journal-title":"J Acoust Soc Am"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0041","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1540-8175.2001.00239.x","article-title":"Ultrasound-enhanced thrombolysis","volume":"18","author":"Francis","year":"2001","journal-title":"Echocardiography"},{"key":"10.1016\/j.ajps.2018.12.004_bib0042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jddst.2014.12.001","article-title":"Fibrin degradation during sonothrombolysis-Effect of ultrasound, microbubbles and tissue plasminogen activator","volume":"25","author":"Petit","year":"2015","journal-title":"J Drug DelivSci Tec"},{"issue":"5","key":"10.1016\/j.ajps.2018.12.004_bib0043","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.thromres.2015.08.027","article-title":"Thrombolytic therapy with rt-PA and transcranial color Doppler ultrasound (TCCS) combined with microbubbles for embolic thrombus","volume":"136","author":"Ren","year":"2015","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0044","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11239-013-0950-8","article-title":"The ultrasound contrast imaging properties of lipid microbubbles loaded with urokinase in dog livers and their thrombolytic effects when combined with low-frequency ultrasound in vitro","volume":"37","author":"Ren","year":"2014","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11239-007-0044-6","article-title":"Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke","volume":"25","author":"Perren","year":"2008","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.ajps.2018.12.004_bib0046","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7863\/ultra.16.04059","article-title":"Characteristics and echogenicity of clinical ultrasound contrast agents: an in vitro and in vivo comparison study","volume":"36","author":"Hyvelin","year":"2017","journal-title":"J Ultrasound Med"},{"issue":"10","key":"10.1016\/j.ajps.2018.12.004_bib0047","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ultrasmedbio.2008.02.011","article-title":"Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?","volume":"34","author":"Rubiera","year":"2008","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"10.1016\/j.ajps.2018.12.004_bib0048","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.thromres.2006.06.009","article-title":"Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes","volume":"119","author":"Tiukinhoy-Laing","year":"2007","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ultrasmedbio.2009.08.009","article-title":"Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes","volume":"36","author":"Smith","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.thromres.2009.01.008","article-title":"Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes","volume":"124","author":"Shaw","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ajps.2018.12.004_bib0051","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.thromres.2011.11.010","article-title":"Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model","volume":"130","author":"Laing","year":"2012","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0052","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11239-015-1204-8","article-title":"Thrombolytic efficacy and enzymatic activity of rt-PA-loaded echogenic liposomes","volume":"40","author":"Bader","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0053","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1088\/1361-6560\/62\/2\/517","article-title":"In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas","volume":"62","author":"Shekhar","year":"2017","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0054","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2010.07.127","article-title":"An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy","volume":"147","author":"Uesugi","year":"2010","journal-title":"J Control Release"},{"issue":"24","key":"10.1016\/j.ajps.2018.12.004_bib0055","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2012.08.1008","article-title":"A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound","volume":"60","author":"Kawata","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1\u20132","key":"10.1016\/j.ajps.2018.12.004_bib0056","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijpharm.2012.06.001","article-title":"Ultrasound-triggered thrombolysis using urokinase-loaded nanogels","volume":"434","author":"Jin","year":"2012","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0057","first-page":"102","article-title":"In vivo evaluation of urokinase-loaded hollow nanogels for sonothrombolysis on suture embolization-induced acute ischemic stroke rat model","volume":"3","author":"Teng","year":"2018","journal-title":"Bioact Mater"},{"key":"10.1016\/j.ajps.2018.12.004_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2018.06.027","article-title":"Stable cavitation using acoustic phase-change dodecafluoropentane nanoparticles for coronary micro-circulation thrombolysis","volume":"272","author":"Hu","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajps.2018.12.004_bib0059","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2013.11.013","article-title":"Recent advances in molecular, multimodal and theranostic ultrasound imaging","volume":"72","author":"Kiessling","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.ajps.2018.12.004_bib0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1160\/TH14-03-0286","article-title":"Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics","volume":"113","author":"Ammi","year":"2015","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.ajps.2018.12.004_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168909","article-title":"Combined low-frequency ultrasound and urokinase-containing microbubbles in treatment of femoral artery thrombosis in a rabbit model","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ajps.2018.12.004_bib0062","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/138161212800099955","article-title":"How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles","volume":"18","author":"Azmin","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0063","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ultrasmedbio.2014.08.018","article-title":"Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis","volume":"41","author":"Bader","year":"2015","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0064","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/17425247.2014.868434","article-title":"Properties, characteristics and applications of microbubbles for sonothrombolysis","volume":"11","author":"de Saint","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"Suppl 2","key":"10.1016\/j.ajps.2018.12.004_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000203127","article-title":"Microbubbles for thrombolysis of acute ischemic stroke","volume":"27","author":"Meairs","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0066","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/11316850-000000000-00000","article-title":"Sonothrombolysis in the management of acute ischemic stroke","volume":"10","author":"Rubiera","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"issue":"21","key":"10.1016\/j.ajps.2018.12.004_bib0067","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1056\/NEJMoa041175","article-title":"Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke","volume":"351","author":"Alexandrov","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajps.2018.12.004_bib0068","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s12272-012-1203-7","article-title":"Promising iron oxide-based magnetic nanoparticles in biomedical engineering","volume":"35","author":"Tran","year":"2012","journal-title":"Arch Pharm Res"},{"issue":"9","key":"10.1016\/j.ajps.2018.12.004_bib0069","doi-asserted-by":"crossref","first-page":"E1837","DOI":"10.3390\/ijms18091837","article-title":"Synthesis and characterization of tissue plasminogen activator-functionalized superparamagnetic iron oxide nanoparticles for targeted fibrin clot dissolution","volume":"18","author":"Heid","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.carbpol.2010.11.052","article-title":"Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator","volume":"84","author":"Chen","year":"2011","journal-title":"Carbohyd Polym"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0071","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/21655979.2016.1227145","article-title":"Thrombolysis based on magnetically-controlled surface-functionalized Fe3O4 nanoparticle","volume":"8","author":"Chang","year":"2017","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0072","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijpharm.2015.09.008","article-title":"Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases","volume":"495","author":"Tadayon","year":"2015","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.ajps.2018.12.004_bib0073","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2016.02.011","article-title":"Targeted thrombolysis of tissue plasminogen activator and streptokinase with extracellular biosynthesis nanoparticles using optimized Streptococcus equi supernatant","volume":"501","author":"Tadayon","year":"2016","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.ajps.2018.12.004_bib0074","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.thromres.2007.08.017","article-title":"Improvement of in vitro thrombolysis employing magnetically-guided microspheres","volume":"121","author":"Torno","year":"2008","journal-title":"Thromb Res"},{"issue":"1\u20132","key":"10.1016\/j.ajps.2018.12.004_bib0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejps.2008.06.012","article-title":"Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers","volume":"35","author":"Kaminski","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2018.12.004_bib0076","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmmm.2016.10.122","article-title":"Preparation of thermosensitive magnetic liposome encapsulated recombinant tissue plasminogen activator for targeted thrombolysis","volume":"427","author":"Hsu","year":"2016","journal-title":"J Magn Mag Mater"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0077","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.addr.2009.11.002","article-title":"Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging","volume":"62","author":"Veiseh","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11684-017-0497-8","article-title":"Translational initiatives in thrombolytic therapy","volume":"11","author":"Klegerman","year":"2017","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0079","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.msec.2009.01.017","article-title":"Design of biomedical nanodevices for dissolution of blood clots","volume":"29","author":"Yurko","year":"2009","journal-title":"Mater Sci Eng C"},{"issue":"4","key":"10.1016\/j.ajps.2018.12.004_bib0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/nnm.11.21","article-title":"A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke","volume":"6","author":"Marsh","year":"2011","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0081","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.thromres.2008.11.019","article-title":"In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound","volume":"124","author":"Alonso","year":"2009","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0082","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI81470","article-title":"A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation","volume":"126","author":"Fuentes","year":"2016","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.ajps.2018.12.004_bib0083","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCRESAHA.114.302514","article-title":"Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets","volume":"114","author":"Wang","year":"2014","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ajps.2018.12.004_bib0084","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7150\/thno.14514","article-title":"Thrombus-targeted theranostic microbubbles: a new technology towards concurrent rapid ultrasound diagnosis and bleeding-free fibrinolytic treatment of thrombosis","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-014-1071-8","article-title":"In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model","volume":"38","author":"Hua","year":"2014","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.ajps.2018.12.004_bib0086","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejps.2011.10.004","article-title":"Platelets directed liposomes for the delivery of streptokinase: development and characterization","volume":"44","author":"Vaidya","year":"2011","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.ajps.2018.12.004_bib0087","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/jth.12321","article-title":"Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study","volume":"11","author":"Hagisawa","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajps.2018.12.004_bib0088","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.avsg.2017.05.011","article-title":"Intravenous targeted microbubbles carrying urokinase versus urokinase alone in acute peripheral arterial thrombosis in a porcine model","volume":"44","author":"Nederhoed","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0089","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/10717544.2014.916770","article-title":"Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro\/in vivo studies","volume":"23","author":"Vaidya","year":"2016","journal-title":"Drug Deliv"},{"issue":"8","key":"10.1016\/j.ajps.2018.12.004_bib0090","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1021\/am406008k","article-title":"Construction and evaluation of Fe3O4-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis","volume":"6","author":"Zhou","year":"2014","journal-title":"Acs Appl Mater Interfaces"},{"issue":"11","key":"10.1016\/j.ajps.2018.12.004_bib0091","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.biomaterials.2007.12.015","article-title":"Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2018.12.004_bib0092","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.actbio.2018.01.038","article-title":"Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis","volume":"70","author":"Zhang","year":"2018","journal-title":"Acta Biomater"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0093","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nano.2017.12.022","article-title":"A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots","volume":"14","author":"Seo","year":"2018","journal-title":"Nanomedicine"},{"issue":"25","key":"10.1016\/j.ajps.2018.12.004_bib0094","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1016\/j.biomaterials.2011.08.067","article-title":"Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery","volume":"32","author":"Modery","year":"2011","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ajps.2018.12.004_bib0095","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-013-1011-x","article-title":"Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy","volume":"30","author":"Absar","year":"2013","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0096","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2011.09.060","article-title":"Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis","volume":"157","author":"Absar","year":"2012","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0097","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.thromres.2012.11.030","article-title":"Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis","volume":"131","author":"Absar","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajps.2018.12.004_bib0098","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2013.12.036","article-title":"Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis","volume":"177","author":"Absar","year":"2014","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0099","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10611860601140673","article-title":"Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes","volume":"15","author":"Tiukinhoy-Laing","year":"2007","journal-title":"J Drug Target"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11596-018-1896-z","article-title":"Recombinant tissue plasminogen activator-conjugated nanoparticles effectively targets thrombolysis in a rat model of middle cerebral artery occlusion","volume":"38","author":"Deng","year":"2018","journal-title":"Curr Med Sci"},{"issue":"Pt A","key":"10.1016\/j.ajps.2018.12.004_bib0101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0102","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ajps.2018.12.004_bib0103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/tde.15.34","article-title":"Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier","volume":"6","author":"Villa","year":"2015","journal-title":"Ther Deliv"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tmrv.2016.08.004","article-title":"Erythrocytes as carriers for drug delivery in blood transfusion and beyond","volume":"31","author":"Villa","year":"2017","journal-title":"Transfus Med Rev"},{"issue":"4","key":"10.1016\/j.ajps.2018.12.004_bib0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.transci.2017.07.015","article-title":"Erythrocyte-based drug delivery in transfusion medicine: wandering questions seeking answers","volume":"56","author":"Tzounakas","year":"2017","journal-title":"Trasfus Apher Sci"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-4165(86)90184-4","article-title":"Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot","volume":"884","author":"Muzykantov","year":"1986","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.ajps.2018.12.004_bib0107","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt846","article-title":"Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes","volume":"21","author":"Murciano","year":"2003","journal-title":"Nat Biotechnol"},{"issue":"14","key":"10.1016\/j.ajps.2018.12.004_bib0108","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.107.750257","article-title":"Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator","volume":"118","author":"Danielyan","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0109","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/jpet.109.159194","article-title":"Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis","volume":"332","author":"Zaitsev","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2009.07.003","article-title":"Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile","volume":"139","author":"Murciano","year":"2009","journal-title":"J Control Release"},{"issue":"25","key":"10.1016\/j.ajps.2018.12.004_bib0111","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajps.2018.12.004_bib0112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.expneurol.2011.10.029","article-title":"Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan","volume":"233","author":"Pisapia","year":"2012","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0113","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.104.075770","article-title":"Blood clearance and activity of erythrocyte-coupled fibrinolytics","volume":"312","author":"Ganguly","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.ajps.2018.12.004_bib0114","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1124\/jpet.105.093450","article-title":"Fibrin affinity of erythrocyte-coupled tissue-type plasminogen activators endures hemodynamic forces and enhances fibrinolysis in vivo","volume":"316","author":"Ganguly","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ajps.2018.12.004_bib0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.transci.2016.04.013","article-title":"Smart blood cell and microvesicle-based Trojan horse drug delivery: merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine","volume":"54","author":"Wu","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.ajps.2018.12.004_bib0116","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/acsnano.8b01772","article-title":"Erythrocyte membrane modified janus polymeric motors for thrombus therapy","volume":"12","author":"Shao","year":"2018","journal-title":"Acs Nano"},{"issue":"12","key":"10.1016\/j.ajps.2018.12.004_bib0117","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1021\/acsnano.8b06021","article-title":"Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots","volume":"12","author":"Colasuonno","year":"2018","journal-title":"Acs Nano"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808761831208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808761831208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:43:38Z","timestamp":1761723818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S181808761831208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S181808761831208X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2018.12.004","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent strategies on targeted delivery of thrombolytics","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}